# 3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer

> **NCT01296672** · PHASE4 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 383 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Finasteride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01296672
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2016-11
- **Final completion:** 2017-01
- **Target enrollment:** 383 (ACTUAL)
- **Last updated:** 2017-10-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01296672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01296672, "3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01296672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*